Stem cells control their own fate, making lab-grown tissues less effective


False colour microscope image of lab-grown muscle tissue

Understanding how stem cells interact with their surroundings could lead to better lab-grown tissues

Tissues grown in the lab from stem cells may fail to live up their therapeutic promise because the cells choose their own fate.

For the last 20 years, scientists have worked to engineer tissues for use in a range of conditions, such as osteoarthritis or heart failure. They do this by placing stem cells – those that can become any kind of cell – in biodegradable 3D structures, or ‘scaffolds’, in the laboratory.

However, lab-grown tissues often fail to be fully effective as treatments when transplanted into patients.

Now, researchers from King’s College London, Imperial College London, University College London and the Francis Crick Institute, have uncovered that feedback between the cells and their scaffold may be the underlying factor, with the resulting signals altering the path the cells take as they grow and mature (their ‘cell fate’).

According to the team, the findings could help to improve the quality of lab-grown tissues, potentially improving outcomes for patients.

“Engineering tissues to replace damaged or diseased tissue could ultimately help patients with a variety of conditions, including cancer,” said Dr Holger Auner from the Department of Medicine, a blood cancer specialist and one of the Imperial College London authors on the paper. “We hope that this insight will also help us to study how cancer cells interact with the tissue that surrounds them, which may lead to better therapies.”

Altered instructions

When tissues are engineered in the lab, the 3D scaffolds contain instructions to direct the stem cells inside how to differentiate – nudging them along the path from a ‘blank’ template capable of becoming multiple cells types, towards a final cell type – such as heart, lung or skin cells.

However, the latest study found that stem cells quickly modify their 3D scaffold, changing both its composition and stiffness, rendering the instructive cues ineffective. The cells then rely on this new self-assembled matrix to direct their own differentiation, rather than cues from the scaffold they were originally placed within.  

Engineering tissues to replace damaged or diseased tissue could ultimately help patients with a variety of conditions, including cancer Dr Holger Auner

Writing in the journal Nature Communications, the researchers explain how human stem cells derived from the bone marrow responded to their surroundings as they developed.

Once placed within the 3D scaffolds, the cells either secreted proteins around themselves, creating a stiff nest-like structure, or released factors that degrade and soften their surroundings.

It was these modifications that then told the stem cells how to differentiate, rather than just the initial cues from the scaffold, as designed.

The team’s findings suggest that researchers will have to re-think how best to design 3D scaffolds to create replacement tissues, as the scaffolds themselves may not directly instruct stem cells how to differentiate and form tissues.

“The positive side of this discovery is that now we know cells make these modifications and it impacts their fate,” explained Dr Eileen Gentleman of King’s, who led the research.

“When we provide stem cells with a 3D structure to help them form a tissue, we have to remember that they will modify the environment we present to them.

"To really coax them to form the tissue we want, we have to find ways to harness this effect so that the local environment they create is one that will drive their differentiation down the correct path.”


Bi-directional cell-pericellular matrix interactions direct stem cell fate’ by Silvia Ferreira, Meghna Motwani, et al. is published in Nature Communications. DOI: 10.1038/s41467-018-06183-4

Image: Lab-grown muscle (Credit: Flickr / NHI -- Photographer: Nenad Bursac, Ph.D., Duke University)

This article is based on materials provided by King's College London.


Ryan O'Hare

Ryan O'Hare
Communications Division

Click to expand or contract

Contact details

Tel: +44 (0)20 7594 2410

Show all stories by this author


Cancer, Strategy-collaboration, Stem-cells, 4IR
See more tags

Leave a comment

Your comment may be published, displaying your name as you provide it, unless you request otherwise. Your contact details will never be published.